|
Federal
Register Notices > Notices of
Registration - 2006
>
Sigma Aldrich Research BioChemicals, Inc.
FR Doc E6-20737 [Federal Register: December 7, 2006 (Volume 71, Number 235)]
[Notices] [Page 70989-70990] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr07de06-89]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated July 10, 2006, and published in the Federal Register on July
24, 2006, (71 FR 41838-41839), Sigma Aldrich Research BioChemicals, Inc., 1-3
Strathmore Road, Natick, Massachusetts 01760, made application by renewal to the
Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of
the basic classes of controlled substances listed in schedule I and II:
|
Drug
|
Schedule
|
|
Cathinone (1235)
|
I
|
|
Methcathinone (1237)
|
I
|
|
Aminorex (1585)
|
I
|
|
Alpha-ethyltryptamine (7249)
|
I
|
|
Lysergic acid diethylamide (7315)
|
I
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
4-Bromo-2,5-dimethoxyampheta- mine (7391)
|
I
|
|
4-Bromo-2,5-dimethoxyphenethylamine (7392)
|
I
|
|
2,5-Dimethoxyampheta- mine (7396)
|
I
|
|
3,4-Methylenedioxyamphetamine (7400)
|
I
|
|
N-Hydroxy-3,4-methylenedioxyamphetamine (7402)
|
I
|
|
3,4-Methylenedioxy-N-ethylamphetamine (7404)
|
I
|
|
3,4-Methylenedioxymeth- amphetamine (MDMA)(7405)
|
I
|
|
1-[1-(2-Thienyl)cyclohexyl]piperidine (TCP) (7470)
|
I
|
|
1-Benzylpiperazine (BZP) (7493)
|
I
|
|
Heroin (9200)
|
I
|
|
Normorphine (9313)
|
I
|
|
Amphetamine (1100)
|
II
|
|
Methamphetamine (1105)
|
II
|
|
Nabilone (7379)
|
II
|
|
1-Phenylcyclohexylamine (7460)
|
II
|
|
Phencyclidine (7471)
|
II
|
|
Cocaine (9041)
|
II
|
|
Codeine (9050)
|
II
|
|
Diprenorphine (9058)
|
II
|
|
Ecgonine (9180)
|
II
|
|
Levomethorphan (9210)
|
II
|
|
Levorphanol (9220)
|
II
|
|
Meperidine (9230)
|
II
|
|
Metazocine (9240)
|
II
|
|
Methadone (9250)
|
II
|
|
Morphine (9300)
|
II
|
|
Thebaine (9333)
|
II
|
|
Levo-alphacetylmethadol (9648)
|
II
|
|
Carfentanil (9743)
|
II
|
|
Fentanyl (9801)
|
II
|
The company plans to manufacture reference standards.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of Sigma Aldrich
Research BioChemicals, Inc. to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this time. DEA
has investigated Sigma Aldrich Research BioChemicals, Inc. to ensure that the
company's registration is consistent with the public interest. The investigation
has included inspection and testing of the company's physical security systems,
verification of the company's compliance with State and local laws, and a review
of the company's background and history. Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR
1301.33, the above named company is granted
registration as a bulk manufacturer of the basic classes of controlled
substances listed.
Dated: November 28, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration.
[FR Doc. E6-20737 Filed 12-6-06; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|
